$SCWO
374Water Inc Stock $scwo

$scwo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424003957 Filed on March 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$315.3K	$744.0K	$744.0K
YoY Change	-60.66%	-5.71%	-75.33%
Cost Of Revenue	$617.3K	$1.852M	$1.852M
YoY Change	-14.28%	158.64%	-30.86%
Gross Profit	-$302.0K	-$1.108M	-$1.108M
YoY Change	-471.43%	-1620.25%	-429.35%
Gross Profit Margin	-95.79%	-148.97%	-148.97%
Selling, General & Admin	$1.364M	$6.038M	$6.038M
YoY Change	-2.85%	319.18%	51.75%
% of Gross Profit
Research & Development	$535.1K	$1.496M	$1.496M
YoY Change	50.36%	286.7%	34.36%
% of Gross Profit
Depreciation & Amortization	$7.632K	$25.82K	$85.82K
YoY Change	-19.87%	47.37%	3407.15%
% of Gross Profit
Operating Expenses	$1.899M	$7.535M	$7.535M
YoY Change	7.91%	312.3%	47.95%
Operating Profit	-$2.201M	-$8.643M	-$8.643M
YoY Change	31.13%	392.6%	81.72%
Interest Expense	$104.6K	$446.7K	$446.7K
YoY Change	176.33%	582.46%	565.98%
% of Operating Profit
Other Income/Expense, Net	$176.7K	$92.69K	$92.69K
YoY Change	362.17%	-10285.71%	40.09%
Pretax Income	-$2.024M	-$8.104M	-$8.104M
YoY Change	23.42%	379.5%	72.78%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$2.024M	-$8.104M	-$8.104M
YoY Change	23.42%	379.5%	72.78%
Net Earnings / Revenue	-642.12%	-1089.26%	-1089.26%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	-$0.06	-$0.06
COMMON SHARES
Basic Shares Outstanding	132.7M shares	132.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.936M	$10.45M	$10.45M
YoY Change	-28.59%	74.34%	74.34%
Cash & Equivalents	$7.936M	$10.45M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$921.4K	$581.1K	$581.1K
YoY Change	607.82%	278.66%	278.66%
Inventory	$2.602M	$2.277M	$2.277M
Prepaid Expenses	$921.4K	$581.1K
Receivables	$84.32K	$1.559M	$1.559M
Other Receivables	$34.16K	$39.74K	$39.74K
Total Short-Term Assets	$13.35M	$14.90M	$14.90M
YoY Change	-11.24%	70.82%	70.82%
LONG-TERM ASSETS
Property, Plant & Equipment	$223.3K	$231.0K	$231.0K
YoY Change	58.56%	61.43%	61.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.195M	$1.219M	$1.219M
YoY Change	1.56%	2.17%	2.17%
TOTAL ASSETS
Total Short-Term Assets	$13.35M	$14.90M	$14.90M
Total Long-Term Assets	$1.195M	$1.219M	$1.219M
Total Assets	$14.54M	$16.12M	$16.12M
YoY Change	-10.31%	62.56%	62.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$755.7K	$572.3K	$572.3K
YoY Change	-12.94%	-60.52%	-60.52%
Accrued Expenses	$735.0K	$635.0K	$635.0K
YoY Change
Deferred Revenue	$132.8K	$130.0K
YoY Change	-35.27%	-35.04%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.634M	$1.374M	$1.374M
YoY Change	52.26%	-17.38%	-17.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.634M	$1.374M	$1.374M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.634M	$1.374M	$1.374M
YoY Change	52.26%	-17.38%	-17.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.98M	-$15.95M
YoY Change	89.43%	103.23%
Common Stock	$13.27K	$13.27K
YoY Change	2.97%	4.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$12.91M	$14.75M	$14.75M
YoY Change
Total Liabilities & Shareholders Equity	$14.54M	$16.12M	$16.12M
YoY Change	-10.31%	62.56%	62.56%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.024M	-$8.104M	-$8.104M
YoY Change	23.42%	379.5%	72.78%
Depreciation, Depletion And Amortization	$7.632K	$25.82K	$85.82K
YoY Change	-19.87%	47.37%	3407.15%
Cash From Operating Activities	-$2.509M	-$2.335M	-$9.035M
YoY Change	-21.07%	-0.67%	82.56%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$51.72K	$111.7K
YoY Change	-100.0%	-28.02%	-22.72%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.963M	$1.963M
YoY Change		-51.36%	-200.0%
Cash From Investing Activities	-$590.00	$1.912M	$1.852M
YoY Change	-94.1%	-51.78%	-185.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$13.58M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-1.931M	13.58M
YoY Change	-100.0%	-7808.82%	54109.51%
NET CHANGE
Cash From Operating Activities	-$2.509M	-2.335M	-9.035M
Cash From Investing Activities	-$590.00	1.912M	1.852M
Cash From Financing Activities	$0.00	-1.931M	13.58M
Net Change In Cash	-$2.509M	-2.354M	6.396M
YoY Change	-149.14%	-243.65%	-190.28%
FREE CASH FLOW
Cash From Operating Activities	-$2.509M	-$2.335M	-$9.035M
Capital Expenditures	$0.00	$51.72K	$111.7K
Free Cash Flow	-$2.509M	-$2.387M	-$9.147M
YoY Change	-21.25%	-1.48%	79.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4046937	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	64792	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2023	us-gaap	Gross Profit GrossProfit	-1108256	usd
CY2022	us-gaap	Gross Profit GrossProfit	336501	usd
CY2022	scwo	Weighted Average Remaining Contractual Life Years Ending Balance WeightedAverageRemainingContractualLifeYearsEndingBalance	P1Y11M16D
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000933972
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Trading Symbol TradingSymbol	SCWO
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132667107	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126702545	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Entity File Number EntityFileNumber	000-27866
CY2023	dei	Entity Registrant Name EntityRegistrantName	374WATER INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0271109
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	701 W Main Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 410
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Durham
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27701
CY2023	dei	City Area Code CityAreaCode	919
CY2023	dei	Local Phone Number LocalPhoneNumber	888-8194
CY2023	dei	Security12g Title Security12gTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	291002404	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	132667107	shares
CY2023	dei	Auditor Firm AuditorFirmId	677
CY2023	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2023	dei	Auditor Location AuditorLocation	Raleigh, North Carolina
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10445404	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2909	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	39749	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	0	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1494553	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	918164	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2276677	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1660710	usd
CY2023Q4	us-gaap	Investments Investments	0	usd
CY2022Q4	us-gaap	Investments Investments	1944464	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	581085	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	153455	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14902260	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8723730	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	230971	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143079	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	988029	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1050022	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1219000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1193101	usd
CY2023Q4	us-gaap	Assets Assets	16121260	usd
CY2022Q4	us-gaap	Assets Assets	9916831	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	572297	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1449582	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	500000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2023Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	135000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	0	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	130000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200109	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	36787	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	13528	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2799	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-328	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2799	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19296	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8100723	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4709263	usd
CY2023	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.06
CY2022	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.04
CY2023	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	130367662	shares
CY2022	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	126641536	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12327085	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	610741	usd
CY2022	scwo	Conversion Of Convertible Preferred Shares Into Common Stock Amount ConversionOfConvertiblePreferredSharesIntoCommonStockAmount	-2	usd
CY2022	scwo	Exercised Option And Warrants Amount ExercisedOptionAndWarrantsAmount	25051	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-328	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-18968	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4689967	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8253612	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13441438	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	925181	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	100000	usd
CY2023	scwo	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	37500	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	71200	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	2799	usd
CY2023	scwo	Amortization Of Afs Investment Securities Unrealized Loss In Aoci Into Interest Income As Yield Adjustment AmortizationOfAfsInvestmentSecuritiesUnrealizedLossInAociIntoInterestIncomeAsYieldAdjustment	18968	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8103522	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14747176	usd
CY2023	us-gaap	Profit Loss ProfitLoss	8103522	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4689967	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85816	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	67573	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	925181	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	610741	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	71200	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	64792	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	39749	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
CY2023	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	576389	usd
CY2022	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	918164	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	615967	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1660710	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	427630	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-65011	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-877285	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1386601	usd
CY2023	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	500000	usd
CY2022	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	0	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	135000	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2023	scwo	Increase Decrease In Unearned Revenue IncreaseDecreaseInUnearnedRevenue	-70109	usd
CY2022	scwo	Increase Decrease In Unearned Revenue IncreaseDecreaseInUnearnedRevenue	200109	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	23259	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-9862	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9034987	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4948668	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105990	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	144567	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1963432	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1963432	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	5725	usd
CY2022	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	52292	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1851717	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2160291	usd
CY2023	scwo	Proceeds From The Exercise Of Options And Warrants ProceedsFromTheExerciseOfOptionsAndWarrants	137500	usd
CY2022	scwo	Proceeds From The Exercise Of Options And Warrants ProceedsFromTheExerciseOfOptionsAndWarrants	25049	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13441438	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13578938	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25049	usd
CY2023	scwo	Effect Of Exchange Rates On Cash EffectOfExchangeRatesOnCash	2799	usd
CY2022	scwo	Effect Of Exchange Rates On Cash EffectOfExchangeRatesOnCash	-328	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6398467	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7084238	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4046937	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11131175	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10445404	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4046937	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	scwo	Change In Unrealized Loss On Afs Investment Securities ChangeInUnrealizedLossOnAfsInvestmentSecurities	0	usd
CY2022	scwo	Change In Unrealized Loss On Afs Investment Securities ChangeInUnrealizedLossOnAfsInvestmentSecurities	-18968	usd
CY2023	scwo	Transfers Of Investment Securities From Afs To Htm TransfersOfInvestmentSecuritiesFromAfsToHtm	1963432	usd
CY2022	scwo	Transfers Of Investment Securities From Afs To Htm TransfersOfInvestmentSecuritiesFromAfsToHtm	0	usd
CY2023	scwo	Amortization Of Afs Investment Securities Unrealized Loss In Aoci Into Interest Income As Yield Adjustment AmortizationOfAfsInvestmentSecuritiesUnrealizedLossInAociIntoInterestIncomeAsYieldAdjustment	18968	usd
CY2022	scwo	Amortization Of Afs Investment Securities Unrealized Loss In Aoci Into Interest Income As Yield Adjustment AmortizationOfAfsInvestmentSecuritiesUnrealizedLossInAociIntoInterestIncomeAsYieldAdjustment	0	usd
CY2023Q4	us-gaap	Cash Cash	10445404	usd
CY2022Q4	us-gaap	Cash Cash	4046937	usd
CY2023Q4	scwo	Available For Sale Securities From Investment AvailableForSaleSecuritiesFromInvestment	1963432	usd
CY2023	us-gaap	Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pretax Accumulated Other Comprehensive Income Loss UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss	18968	usd
CY2022Q4	scwo	Investments Adjusted Cost InvestmentsAdjustedCost	6010369	usd
CY2022Q4	scwo	Unrealized Losses UnrealizedLosses	18968	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	5991401	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4046937	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1944464	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2023	us-gaap	Reclassifications Reclassifications	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications of prior year amounts including the effect of exchange rates on cash of $328 on the consolidated statements of cash flows have been made to conform to the 2023 presentation. These reclassifications had no effect on net loss or loss per share as previously reported.</p>
CY2023	scwo	Effect Of Exchange Rate On Cash From Reclassification EffectOfExchangeRateOnCashFromReclassification	328	usd
CY2023	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	2909	usd
CY2022	us-gaap	Allowance For Loan And Lease Losses Writeoffs Net AllowanceForLoanAndLeaseLossesWriteoffsNet	0	usd
CY2023	scwo	Accounts And Receivable Allowance For Credit Loss AccountsAndReceivableAllowanceForCreditLoss	0	usd
CY2022	scwo	Accounts And Receivable Allowance For Credit Loss AccountsAndReceivableAllowanceForCreditLoss	0	usd
CY2023	scwo	Accounts Receivable Allowance For Credit Losses Current Period Provision AccountsReceivableAllowanceForCreditLossesCurrentPeriodProvision	2909	usd
CY2022	scwo	Accounts Receivable Allowance For Credit Losses Current Period Provision AccountsReceivableAllowanceForCreditLossesCurrentPeriodProvision	0	usd
CY2023	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	0	usd
CY2022	us-gaap	Proceeds Accounts Receivable Previously Written Off Recovery ProceedsAccountsReceivablePreviouslyWrittenOffRecovery	0	usd
CY2023	scwo	Recovery From Accounts Receivable RecoveryFromAccountsReceivable	0	usd
CY2022	scwo	Recovery From Accounts Receivable RecoveryFromAccountsReceivable	0	usd
CY2023	scwo	Accounts And Financing Receivables Allowance For Credit Loss AccountsAndFinancingReceivablesAllowanceForCreditLoss	2909	usd
CY2022	scwo	Accounts And Financing Receivables Allowance For Credit Loss AccountsAndFinancingReceivablesAllowanceForCreditLoss	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	251747	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	145756	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20776	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2677	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	230971	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143079	usd
CY2023	us-gaap	Depreciation Depreciation	18098	usd
CY2021	us-gaap	Depreciation Depreciation	2447	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues, purchases, accounts receivables, and accounts payables. One customer made up approximately 88% and 98% of revenue for the year ended December 31, 2023 and 2022, respectively. As of December 31, 2023, one customer accounted for 51% of our outstanding accounts receivable. As of December 31, 2022, we did not have any accounts receivable outstanding. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2023 and 2022, our unbilled receivables of $1,485,803 and $918,164, respectively, were due from one customer and the same customer that comprises the majority of our revenue. The loss of this significant customer could adversely affect the results of our operations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In 2023 and 2022, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 9 for a license agreement we have with Duke University for the SCWO technology used in our systems. </p>
CY2023	scwo	Recent Accounting Pronouncements Not Yet Adoptedpolicypolicytextblock RecentAccountingPronouncementsNotYetAdoptedpolicypolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 FASB issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after Dec. 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Entities should adopt this guidance on a prospective basis, though retrospective application is permitted. The adoption of ASU 2023-09 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In November 2023 the FASB issued ASU 2023-07, <em>Segment Reporting – Improvements to Reportable Segment Disclosures. </em>The ASU will now require public entities to disclose its significant segment expenses categories and amounts for each reportable segment. Under the ASU, a significant segment expense is an expense that is:</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">significant to the segment,</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">regularly provided to or easily computed from information regularly provided to the chief operating decision maker (CODM), and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">included in the reported measure of segment profit or loss.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The ASU is effective for public entities for fiscal years beginning after December 15, 2023 and interim periods in fiscal years beginning after December 15, 2024 (calendar year public entity will adopt the ASU in its 2024 Form 10 K). The ASU should be adopted retrospectively unless it’s impracticable to do so. Early adoption of the ASU is permitted, including in an interim period. The adoption of ASU 2023-07 is expected to have a financial statement disclosure impact only and is not expected to have a material impact on the Company’s financial statements. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p>
CY2023Q4	us-gaap	Capital Capital	13528176	usd
CY2022Q4	us-gaap	Capital Capital	7060511	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15953504	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7849982	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8103522	usd
CY2023	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	9034987	usd
CY2023	scwo	Revenues From Sales RevenuesFromSales	655818	usd
CY2023	scwo	Revenues From Sale Of Treatability Services RevenuesFromSaleOfTreatabilityServices	88134	usd
CY2022	scwo	Revenues From Sales RevenuesFromSales	2952020	usd
CY2022	scwo	Revenues From Sale Of Treatability Services RevenuesFromSaleOfTreatabilityServices	63501	usd
CY2023	scwo	Accrued Contract Loss Provision And Onerous Contractspolicytextblock AccruedContractLossProvisionAndOnerousContractspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. US GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition—Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated. </p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2023, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a contract loss provision of $500,000 which has been presented on the accompanying consolidated balance sheets and is recorded within cost of revenues on the accompanying consolidated statements of operations.</p>
CY2023	us-gaap	Loss Contingency Accrual Provision LossContingencyAccrualProvision	500000	usd
CY2023	scwo	Share Based Description ShareBasedDescription	cumulative adjustment of approximately $55,000 in the quarter ended December 31, 2023 to reduce our forfeiture rate estimate to approximately 5% of the total stock-based compensation recognized during the year
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	457393	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	755218	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1819284	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	905492	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2276677	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1496129	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1113500	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, revenue recognition and accrued loss provisions on onerous contracts, fair value of intangible assets, useful lives of long-lived assets, and valuation allowance against deferred tax assets.</p>
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4689967	usd
CY2022	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	4948668	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1374084	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1663219	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1374084	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1663219	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132667107	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126702545	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	13266	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12669	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30684943	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16110221	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15953504	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7849982	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2471	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19296	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	14747176	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	8253612	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16121260	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9916831	usd
CY2023	us-gaap	Revenues Revenues	743952	usd
CY2022	us-gaap	Revenues Revenues	3015521	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1852208	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2679020	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1496129	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1113500	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2854494	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1644861	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	508795	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	768548	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2675202	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1565723	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	7534620	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5092632	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-8642876	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4756131	usd
CY2023	us-gaap	Interest Income Operating InterestIncomeOperating	446669	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	67067	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	92685	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-903	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	539354	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	66164	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8103522	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4689967	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-8103522	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4689967	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-18968	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1660710	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1050022	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	5725	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67718	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	988029	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1062856	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	52292	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	65126	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1050022	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	67718	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	65126	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	67933	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	67933	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	67933	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	67933	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	67933	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	648364	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	988029	usd
CY2023	us-gaap	Revenues Revenues	743952	usd
CY2023	scwo	Premiums Revenue Percentage PremiumsRevenuePercentage	1	pure
CY2022	us-gaap	Revenues Revenues	3015521	usd
CY2022	scwo	Premiums Revenue Percentage PremiumsRevenuePercentage	1	pure
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200109	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2023	scwo	Billings Deferred Unearned Revenue BillingsDeferredUnearnedRevenue	58000	usd
CY2022	scwo	Billings Deferred Unearned Revenue BillingsDeferredUnearnedRevenue	1467189	usd
CY2023	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	128109	usd
CY2022	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	1267080	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	130000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200109	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	918164	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023	scwo	Services Performed But Unbilled ServicesPerformedButUnbilled	1061612	usd
CY2022	scwo	Services Performed But Unbilled ServicesPerformedButUnbilled	918164	usd
CY2023	scwo	Services Billed ServicesBilled	-485223	usd
CY2022	scwo	Services Billed ServicesBilled	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1494553	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	918164	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	132667107	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	925181	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	610741	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1912257	usd
CY2023	scwo	Unrecognized Compensation Vesting Period UnrecognizedCompensationVestingPeriod	three years
CY2022	scwo	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Warrants Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantsExercised	15000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.50
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	37500	usd
CY2022	scwo	Issuance Of Common Stock IssuanceOfCommonStock	15000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	1.42
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	usd
CY2022	scwo	Weighted Average Remaining Contractual Life Years Beginning Balance WeightedAverageRemainingContractualLifeYearsBeginningBalance	P2Y11M15D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	scwo	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.50
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	450000	usd
CY2023	scwo	Weighted Average Remaining Contractual Life Years Beginning Balance WeightedAverageRemainingContractualLifeYearsBeginningBalance	P1Y11M15D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	15000	shares
CY2023	scwo	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	2.50
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1235000	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023	scwo	Weighted Average Remaining Contractual Life Years Ending Balance WeightedAverageRemainingContractualLifeYearsEndingBalance	P0Y11M15D
CY2023	scwo	Stock In Excess Percentage Of Outstanding Share StockInExcessPercentageOfOutstandingShare	0.05	pure
CY2023	scwo	Related Party Transaction Expenses From Transactions With Related Parties RelatedPartyTransactionExpensesFromTransactionsWithRelatedParties	1210826	usd
CY2023	scwo	Related Party Cost RelatedPartyCost	125282	usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	175000	shares
CY2023	scwo	Legal Settlement Issuable Shares LegalSettlementIssuableShares	275000	shares
CY2023Q4	scwo	Accrued Legal Settlement Current AccruedLegalSettlementCurrent	135000	usd
CY2023Q4	scwo	Exercise Price ExercisePrice	1.33
CY2023	scwo	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rates ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRates	0.0443	pure
CY2023	scwo	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rates ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRates	0.2636	pure
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	151634	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	168897	usd
CY2023Q4	scwo	Deferred Tax Assets Startup Cost DeferredTaxAssetsStartupCost	55077	usd
CY2022Q4	scwo	Deferred Tax Assets Startup Cost DeferredTaxAssetsStartupCost	65305	usd
CY2023Q4	scwo	Deferred Tax Assets Other Intangible Assets DeferredTaxAssetsOtherIntangibleAssets	6808	usd
CY2022Q4	scwo	Deferred Tax Assets Other Intangible Assets DeferredTaxAssetsOtherIntangibleAssets	8068	usd
CY2023Q4	scwo	Deferred Tax Assets Other Intangible Assets Other Accruals DeferredTaxAssetsOtherIntangibleAssetsOtherAccruals	36760	usd
CY2022Q4	scwo	Deferred Tax Assets Other Intangible Assets Other Accruals DeferredTaxAssetsOtherIntangibleAssetsOtherAccruals	17425	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	359378	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	80374	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3561783	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1009495	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	832	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	346	usd
CY2023Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	10499	usd
CY2023Q4	scwo	Deferred Tax Assets Unearned Revenue DeferredTaxAssetsUnearnedRevenue	35399	usd
CY2022Q4	scwo	Deferred Tax Assets Unearned Revenue DeferredTaxAssetsUnearnedRevenue	5763	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	887434	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	353746	usd
CY2023Q4	scwo	Deferred Tax Assets Reserves And Allowances DeferredTaxAssetsReservesAndAllowances	136942	usd
CY2022Q4	scwo	Deferred Tax Assets Reserves And Allowances DeferredTaxAssetsReservesAndAllowances	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5232047	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1698920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5173947	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1665938	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	58100	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	32982	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-58100	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-32982	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	58100	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	32982	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0199	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0002	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4319	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2059	pure
CY2023	scwo	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	0.1070	pure
CY2022	scwo	Income Tax Reconciliation Permanent Differences IncomeTaxReconciliationPermanentDifferences	-0.0180	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0623	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0205	pure
CY2023	scwo	Income Tax Reconciliation Other IncomeTaxReconciliationOther	0.0327	pure
CY2022	scwo	Income Tax Reconciliation Other IncomeTaxReconciliationOther	-0.0068	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	13300000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	11000000.0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1450000	usd

Files In Submission

Name	View Source	Status
0001654954-24-003957-index-headers.html	Edgar Link	pending
0001654954-24-003957-index.html	Edgar Link	pending
0001654954-24-003957.txt	Edgar Link	pending
0001654954-24-003957-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scwo-20231231.xsd	Edgar Link	pending
scwo-20231231_def.xml	Edgar Link	unprocessable
scwo-20231231_lab.xml	Edgar Link	unprocessable
scwo-20231231_pre.xml	Edgar Link	unprocessable
scwo_10k.htm	Edgar Link	pending
scwo_ex1013.htm	Edgar Link	pending
scwo_ex211.htm	Edgar Link	pending
scwo_ex231.htm	Edgar Link	pending
scwo_ex311.htm	Edgar Link	pending
scwo_ex312.htm	Edgar Link	pending
scwo_ex321.htm	Edgar Link	pending
scwo_ex322.htm	Edgar Link	pending
scwo_ex97.htm	Edgar Link	pending
Show.js	Edgar Link	pending
scwo_10k_htm.xml	Edgar Link	completed
scwo-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCWO
374Water Inc Stock $scwo

2024 Q1 Form 10-K Financial Statement

#000165495424003957 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO 374Water Inc Stock $scwo

2024 Q1 Form 10-K Financial Statement

#000165495424003957 Filed on March 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO
374Water Inc Stock $scwo